vs
Cooper Companies (The)（COO）与Sunrun Inc.（RUN）财务数据对比。点击上方公司名可切换其他公司
Sunrun Inc.的季度营收约是Cooper Companies (The)的1.1倍（$1.2B vs $1.1B），Sunrun Inc.净利率更高（8.9% vs 7.9%，领先1.0%），Sunrun Inc.同比增速更快（123.5% vs 4.6%），过去两年Sunrun Inc.的营收复合增速更高（59.0% vs 6.9%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
Sunrun Inc.是美国知名的光伏系统及电池储能产品供应商，业务以服务住宅客户为主，2007年成立，总部位于加利福尼亚州旧金山，致力于为家庭用户提供高效的清洁能源解决方案。
COO vs RUN — 直观对比
营收规模更大
RUN
是对方的1.1倍
$1.1B
营收增速更快
RUN
高出118.9%
4.6%
净利率更高
RUN
高出1.0%
7.9%
两年增速更快
RUN
近两年复合增速
6.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $84.6M | $103.6M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 8.4% |
| 净利率 | 7.9% | 8.9% |
| 营收同比 | 4.6% | 123.5% |
| 净利润同比 | -28.0% | 103.7% |
| 每股收益（稀释后） | $0.42 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COORUN
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $724.6M | ||
| Q2 25 | $1.0B | $569.3M | ||
| Q1 25 | $964.7M | $504.3M | ||
| Q4 24 | $1.0B | $518.5M | ||
| Q3 24 | $1.0B | $537.2M | ||
| Q2 24 | $942.6M | $523.9M | ||
| Q1 24 | $931.6M | $458.2M |
净利润COORUN
| Q4 25 | $84.6M | $103.6M | ||
| Q3 25 | $98.3M | $16.6M | ||
| Q2 25 | $87.7M | $279.8M | ||
| Q1 25 | $104.3M | $50.0M | ||
| Q4 24 | $117.5M | $-2.8B | ||
| Q3 24 | $104.7M | $-83.8M | ||
| Q2 24 | $88.9M | $139.1M | ||
| Q1 24 | $81.2M | $-87.8M |
毛利率COORUN
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — | ||
| Q1 24 | 67.0% | — |
营业利润率COORUN
| Q4 25 | 13.2% | 8.4% | ||
| Q3 25 | 16.6% | 0.5% | ||
| Q2 25 | 18.4% | -19.7% | ||
| Q1 25 | 18.9% | -22.8% | ||
| Q4 24 | 19.5% | -628.0% | ||
| Q3 24 | 19.2% | -23.8% | ||
| Q2 24 | 17.2% | -24.4% | ||
| Q1 24 | 16.4% | -40.0% |
净利率COORUN
| Q4 25 | 7.9% | 8.9% | ||
| Q3 25 | 9.3% | 2.3% | ||
| Q2 25 | 8.7% | 49.1% | ||
| Q1 25 | 10.8% | 9.9% | ||
| Q4 24 | 11.5% | -542.7% | ||
| Q3 24 | 10.4% | -15.6% | ||
| Q2 24 | 9.4% | 26.5% | ||
| Q1 24 | 8.7% | -19.2% |
每股收益（稀释后）COORUN
| Q4 25 | $0.42 | $0.38 | ||
| Q3 25 | $0.49 | $0.06 | ||
| Q2 25 | $0.44 | $1.07 | ||
| Q1 25 | $0.52 | $0.20 | ||
| Q4 24 | $0.59 | $-12.59 | ||
| Q3 24 | $0.52 | $-0.37 | ||
| Q2 24 | $0.44 | $0.55 | ||
| Q1 24 | $0.41 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | — |
| 总债务越低越好 | $2.5B | $14.7B |
| 股东权益账面价值 | $8.2B | $3.1B |
| 总资产 | $12.4B | $22.6B |
| 负债/权益比越低杠杆越低 | 0.30× | 4.69× |
8季度趋势，按日历期对齐
现金及短期投资COORUN
| Q4 25 | $110.6M | — | ||
| Q3 25 | $124.9M | — | ||
| Q2 25 | $116.2M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $107.6M | — | ||
| Q3 24 | $109.7M | — | ||
| Q2 24 | $112.4M | — | ||
| Q1 24 | $135.2M | — |
总债务COORUN
| Q4 25 | $2.5B | $14.7B | ||
| Q3 25 | $2.4B | $14.6B | ||
| Q2 25 | $2.5B | $14.0B | ||
| Q1 25 | $2.5B | $13.6B | ||
| Q4 24 | $2.6B | $12.9B | ||
| Q3 24 | $2.6B | $12.5B | ||
| Q2 24 | $2.7B | $12.0B | ||
| Q1 24 | $2.7B | $11.1B |
股东权益COORUN
| Q4 25 | $8.2B | $3.1B | ||
| Q3 25 | $8.4B | $3.0B | ||
| Q2 25 | $8.3B | $2.9B | ||
| Q1 25 | $8.1B | $2.6B | ||
| Q4 24 | $8.1B | $2.6B | ||
| Q3 24 | $7.9B | $5.3B | ||
| Q2 24 | $7.8B | $5.4B | ||
| Q1 24 | $7.7B | $5.2B |
总资产COORUN
| Q4 25 | $12.4B | $22.6B | ||
| Q3 25 | $12.4B | $22.2B | ||
| Q2 25 | $12.4B | $21.2B | ||
| Q1 25 | $12.2B | $20.4B | ||
| Q4 24 | $12.3B | $19.9B | ||
| Q3 24 | $12.1B | $22.1B | ||
| Q2 24 | $12.0B | $21.4B | ||
| Q1 24 | $12.0B | $20.8B |
负债/权益比COORUN
| Q4 25 | 0.30× | 4.69× | ||
| Q3 25 | 0.29× | 4.90× | ||
| Q2 25 | 0.30× | 4.80× | ||
| Q1 25 | 0.31× | 5.19× | ||
| Q4 24 | 0.32× | 5.05× | ||
| Q3 24 | 0.33× | 2.36× | ||
| Q2 24 | 0.34× | 2.23× | ||
| Q1 24 | 0.35× | 2.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $96.9M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | — |
| 现金转化率经营现金流/净利润 | 2.93× | 0.94× |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COORUN
| Q4 25 | $247.9M | $96.9M | ||
| Q3 25 | $261.4M | $-121.5M | ||
| Q2 25 | $96.2M | $-292.7M | ||
| Q1 25 | $190.6M | $-104.2M | ||
| Q4 24 | $268.1M | $-258.4M | ||
| Q3 24 | $207.5M | $-156.2M | ||
| Q2 24 | $111.0M | $-208.5M | ||
| Q1 24 | $122.7M | $-143.1M |
自由现金流COORUN
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $128.1M | — | ||
| Q3 24 | $118.5M | $-156.4M | ||
| Q2 24 | $36.9M | — | ||
| Q1 24 | $4.6M | — |
自由现金流率COORUN
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.8% | -29.1% | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 0.5% | — |
资本支出强度COORUN
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 8.9% | 0.0% | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 12.7% | — |
现金转化率COORUN
| Q4 25 | 2.93× | 0.94× | ||
| Q3 25 | 2.66× | -7.33× | ||
| Q2 25 | 1.10× | -1.05× | ||
| Q1 25 | 1.83× | -2.08× | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | 1.98× | — | ||
| Q2 24 | 1.25× | -1.50× | ||
| Q1 24 | 1.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
RUN
| Products | $692.3M | 60% |
| Customer Agreements | $435.2M | 38% |
| Manufactured Product Other | $56.7M | 5% |
| Incentives | $31.3M | 3% |
